Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thyroid Cancer Metastatic × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Squamous Cell Carcinoma of Head and Neck 548 Head and Neck Neoplasms 532 Nasopharyngeal Carcinoma 210 Thyroid Neoplasms 122 Oropharyngeal Neoplasms 94 Salivary Gland Neoplasms 82 Carcinoma, Squamous Cell 82 Mouth Neoplasms 79 Nasopharyngeal Neoplasms 71 Recurrence 57 Carcinoma, Non-Small-Cell Lung 55 Laryngeal Neoplasms 53 Neoplasm Metastasis 48 Neoplasms 43 Hypopharyngeal Neoplasms 39 Thyroid Carcinoma, Anaplastic 34 Melanoma 33 Breast Neoplasms 32 Thyroid Cancer, Papillary 31 Lung Neoplasms 27 Tongue Neoplasms 26 Carcinoma 26 Adenocarcinoma, Follicular 24 Stomatitis 23 Colorectal Neoplasms 23 Sarcoma 22 Carcinoma, Medullary 22 Uterine Cervical Neoplasms 20 Ovarian Neoplasms 19 Mucositis 19

Interventions

lenvatinib 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732495 2022-03-29

LENVOS

Centre Leon Berard

Phase 2 Unknown

EndocrineHead & Neck

Thyroid Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡